Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jce.16562 | DOI Listing |
J Cardiovasc Electrophysiol
December 2024
Department of Cardiology, The Prince Charles Hospital, Brisbane, Queensland, Australia.
J Cardiovasc Electrophysiol
December 2024
Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location AMC, The Netherlands.
The extravascular implantable cardioverter-defibrillator (EV-ICD) was developed to overcome complications associated with transvenous leads while being able to deliver anti-tachycardia pacing (ATP). The lead is implanted in the substernal space, which makes extraction a cautious procedure. We present a case of a 51-year-old women with a successful EV-ICD extraction after a lead dwell time of 4 years, which is the longest reported.
View Article and Find Full Text PDFJ Cardiovasc Electrophysiol
November 2024
University of Melbourne, Melbourne, Parkville, Victoria, Australia.
Introduction: Substernal extravascular defibrillators (EV ICDs) have been shown to be effective and safe for patients at risk of sudden cardiac death, however, there is little evidence around the safety of extracting chronic devices.
Methods And Results: We present a 50-year-old patient in whom a Medtronic EV ICD system was successfully removed without specialist extraction tools, 186 weeks after implantation, by an operator experienced in transvenous lead extraction but without formal training in EVICD implantation.
Conclusion: The successful extraction of an EV ICD system is possible without specialised tools at least 3.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!